The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Multi-stakeholder Workshop / November 2019


The Use of Real-World Data to Optimize Oncology Drug Development and Access

Amsterdam, Netherlands – 21 & 22 November 2019


Due to the current interest in Real World Data both from Industry but especially the EMA and FDA, the Cancer Drug Development Forum organized the 2nd CDDF multi-stakeholder workshop on the Use of Real-World Data to Optimize Oncology Drug Development and Access on 21-22 November 2019 in Amsterdam, Netherlands.

The aim of the workshop is to have a multi-stakeholder discussion representing regulators, clinicians, HTA / payers, and policy makers on the challenges of developing RWD proposals in Oncology and share current experience on the best sources of RWD of high quality in Oncology Drug Development. Meeting delegates discussed ways to enhance knowledge on benefit/risk as well as development and access to optimal treatment regimens.

The second edition focused particularly on issues concerning methodology of collecting good quality and relevant information, and the specific requirement of Regulators to maximise the use of RWD in licensing decisions. Meeting participants also explored possible solutions to the current challenges and made a call for action.


    • John Smyth (University of Edinburgh – CDDF Board)
    • Nafsika Kronidou Horst (Roche)
    • Stefan Schwoch (Lilly)
    • Eva Skovlund (Norwegian University of Science and Technology, NTNU)


View the speakers’ presentation: slides

Read the executive summary of the RWD meeting

Read the meeting summary online

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70